• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗-D问题:从需求识别到床边给药的一体化无缝衔接方法。

The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration.

作者信息

Ryan M J, Joyce S, O'Brien N, Lynch E, Burke G, Cahill M R

机构信息

Dept of Haematology, Mid-Western Regional Hospital & Regional Maternity Hospital, Limerick.

出版信息

Ir J Med Sci. 2005 Jul-Sep;174(3):58-63. doi: 10.1007/BF03169150.

DOI:10.1007/BF03169150
PMID:16285341
Abstract

BACKGROUND

The appropriate and timely administration of Anti-D immunoglobulin to Rhesus (D) negative women who have delivered Rhesus (D) positive babies is a vital part of obstetric care. Anti-D has an especially high profile in Ireland because of the tragic inadvertent transmission of Hepatitis C to Irish women in past decades.

AUDIT

We have reviewed our policy and procedures pertaining to the administration of Anti-D for sensitising events during pregnancy and postnatally, in the Mid-Western Health Board in 1999/2000. As a result, major changes were made in the storage, issue, recording and administration of Anti-D. New procedures in the transfusion laboratory and in the maternity hospital have been accepted by scientists and midwives and supported by haematology and obstetric medical staff. The pharmacy and haematology laboratory no longer have a role in this programme. IMPLEMENTATION OF MULTI-DISCIPLINARY CHANGE MANAGEMENT: As a result of these changes, the storage, issuing and tracking of Anti-D has become the responsibility of the hospital blood bank. Measurement offoeto-maternal haemorrhage (FMH) is now the responsibility of bio medical scientists in blood bank, utilising both flow cytometry (increasingly recognised as the gold standard method) and the Kleihauer method (Kleihauer-Betke). The programme has moved from a doctor-administered IV Anti-D Ig, to a midwife-administered IM preparation. Prescription remains the responsibility of the doctor. These changes are facilitated by the protocol guided issue of the appropriate dose of Anti-D Ig by bio medical scientists to midwives. The issue of the Anti-D Ig occurs simultaneously with issue of results of mother and baby's serology testing and estimation of volume of FMH. These major changes have been guided by audit and needs assessment and require close liaison between medical, nursing and laboratory scientific staff in haematology, transfusion and obstetrics. CRITICAL INCIDENT AUDIT-CASE REPORT: Before new procedures became official policy, a critical incident audit allowed us to pilot our protocol and to revise it using draft new procedures. In this critical incident we describe successful management of a patient with a large foeto-maternal haemorrhage. This incident supported the need for the procedural enhancements already underway. This critical incident re-emphasised the need for the planned systems improvements to be introduced quickly.

摘要

背景

对分娩出恒河猴(D)阳性婴儿的恒河猴(D)阴性女性及时恰当地给予抗D免疫球蛋白是产科护理的重要组成部分。由于过去几十年丙型肝炎意外传播给爱尔兰女性的悲剧事件,抗D在爱尔兰备受关注。

审核

我们回顾了1999/2000年中西部健康委员会关于孕期及产后抗D用于致敏事件管理的政策和程序。结果,抗D的储存、发放、记录和管理发生了重大变化。输血实验室和妇产医院的新程序已被科学家和助产士接受,并得到血液学和产科医务人员的支持。药房和血液学实验室不再参与该项目。

多学科变革管理的实施

由于这些变化,抗D的储存、发放和追踪已成为医院血库的职责。现在,母婴出血(FMH)的测量由血库的生物医学科学家负责,他们使用流式细胞术(越来越被视为金标准方法)和克列豪尔法(克列豪尔-贝特克法)。该项目已从医生静脉注射抗D免疫球蛋白改为助产士肌肉注射制剂。处方仍由医生负责。生物医学科学家按照方案指导向助产士发放适当剂量的抗D免疫球蛋白,促进了这些变化。抗D免疫球蛋白的发放与母婴血清学检测结果及FMH量的估计同时进行。这些重大变化是在审核和需求评估的指导下进行的,需要血液学、输血和产科领域的医疗、护理和实验室科研人员密切联络。

关键事件审核——病例报告:在新程序成为官方政策之前,一次关键事件审核使我们能够试用方案并使用新程序草案对其进行修订。在这次关键事件中,我们描述了对一名母婴大量出血患者的成功管理。这一事件支持了对正在进行的程序改进的需求。这次关键事件再次强调了迅速引入计划中的系统改进的必要性。

相似文献

1
The issue of anti-D: an integrated seamless approach from recognition of need to bedside administration.抗-D问题:从需求识别到床边给药的一体化无缝衔接方法。
Ir J Med Sci. 2005 Jul-Sep;174(3):58-63. doi: 10.1007/BF03169150.
2
Prevention of Rh alloimmunization.预防Rh血型同种免疫。
J Obstet Gynaecol Can. 2003 Sep;25(9):765-73. doi: 10.1016/s1701-2163(16)31006-4.
3
On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.关于Rh免疫球蛋白(抗-D)预防的免疫学基础。
Transfusion. 2006 Sep;46(9):1652-6. doi: 10.1111/j.1537-2995.2006.00924_1.x.
4
Implementation of the rhesus prevention programme: a prospective study.
Scott Med J. 1994 Oct;39(5):147-9. doi: 10.1177/003693309403900509.
5
[Guideline for prevention of RhD alloimmunizationin RhD negative women].[RhD阴性女性RhD同种免疫预防指南]
Ceska Gynekol. 2013 Apr;78(2):132-3.
6
Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.前瞻性定量分析扩宫排空术的胎儿-母体出血。
Contraception. 2019 May;99(5):281-284. doi: 10.1016/j.contraception.2018.11.015. Epub 2018 Nov 27.
7
[Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin].[对有指征使用抗-D免疫球蛋白的产后患者母胎输血情况的评估]
Cad Saude Publica. 2005 Sep-Oct;21(5):1357-65. doi: 10.1590/s0102-311x2005000500007. Epub 2005 Sep 12.
8
Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.临床隐匿性大量胎儿-母体出血:一个典型病例的重要启示
Lab Hematol. 2012 Jun;18(2):11-3. doi: 10.1532/LH96.12002.
9
Assessment of feto-maternal hemorrhage among rhesus D negative pregnant mothers using the kleihauer-betke test (KBT) and flow cytometry (FCM) in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴使用克来豪尔-贝特克试验(KBT)和流式细胞术(FCM)对恒河猴D阴性孕妇进行母胎输血评估。
BMC Pregnancy Childbirth. 2014 Nov 7;14:358. doi: 10.1186/1471-2393-14-358.
10
[Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].[凝胶凝集试验——恒河猴血型不合中母胎输血半定量检测的新测试系统]
Z Geburtshilfe Neonatol. 1999 Nov-Dec;203(6):241-5.

本文引用的文献

1
Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers.重组抗RhD在健康RhD阴性男性志愿者中的药代动力学及安全性
Transfus Med. 2004 Apr;14(2):165-71. doi: 10.1111/j.0958-7578.2004.0493.x.
2
Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion.血液监测与减少输血使用及提高输血合理性相关。
Vox Sang. 2003 Aug;85(2):121-2. doi: 10.1046/j.1423-0410.2003.00322.x.
3
Semiautomated data analysis of flow cytometric estimation of fetomaternal hemorrhage in D- women.
D型阴性女性胎儿-母体出血流式细胞术估计的半自动数据分析
Transfusion. 2002 Aug;42(8):1067-78. doi: 10.1046/j.1537-2995.2002.00159.x.
4
A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.
Vox Sang. 1999;76(3):175-80. doi: 10.1159/000031045.
5
Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.一批受污染的抗-D免疫球蛋白制剂不同批次的丙型肝炎病毒传播率。
Vox Sang. 1999;76(3):138-43. doi: 10.1159/000031038.
6
Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.Rh 预防用抗 D 免疫球蛋白的使用建议。英国输血协会和皇家妇产科医师学院。
Transfus Med. 1999 Mar;9(1):93-7. doi: 10.1046/j.1365-3148.1999.009001093.x.
7
The estimation of fetomaternal haemorrhage. BCSH Blood Transfusion and Haematology Task Forces.胎儿-母体出血的评估。英国血液学标准委员会输血与血液学特别工作组。
Transfus Med. 1999 Mar;9(1):87-92.
8
The prevention of Rh haemolytic disease of the fetus and newborn--general background.胎儿及新生儿溶血病(Rh血型)的预防——一般背景知识
Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:7-10. doi: 10.1111/j.1471-0528.1998.tb10285.x.
9
RhD hemolytic disease of the newborn.新生儿RhD溶血病
N Engl J Med. 1998 Dec 10;339(24):1775-7. doi: 10.1056/NEJM199812103392410.
10
Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists consensus conference on anti-D prophylaxis 7 & 8 April 1997.爱丁堡皇家内科医师学院/皇家妇产科学院抗D预防共识会议,1997年4月7日和8日
Transfus Med. 1997 Jun;7(2):143-4. doi: 10.1046/j.1365-3148.1997.d01-20.x.